GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (ASX:AFP) » Definitions » Operating Margin %

AFT Pharmaceuticals (ASX:AFP) Operating Margin % : 2.04% (As of Sep. 2023)


View and export this data going back to 2015. Start your Free Trial

What is AFT Pharmaceuticals Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. AFT Pharmaceuticals's Operating Income for the six months ended in Sep. 2023 was A$1.6 Mil. AFT Pharmaceuticals's Revenue for the six months ended in Sep. 2023 was A$76.6 Mil. Therefore, AFT Pharmaceuticals's Operating Margin % for the quarter that ended in Sep. 2023 was 2.04%.

The historical rank and industry rank for AFT Pharmaceuticals's Operating Margin % or its related term are showing as below:

ASX:AFP' s Operating Margin % Range Over the Past 10 Years
Min: -25.1   Med: 6.37   Max: 14.36
Current: 9.34


ASX:AFP's Operating Margin % is ranked better than
60.22% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 6.09 vs ASX:AFP: 9.34

AFT Pharmaceuticals's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

AFT Pharmaceuticals's Operating Income for the six months ended in Sep. 2023 was A$1.6 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2023 was A$15.0 Mil.


AFT Pharmaceuticals Operating Margin % Historical Data

The historical data trend for AFT Pharmaceuticals's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Operating Margin % Chart

AFT Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Operating Margin %
Get a 7-Day Free Trial 4.79 9.65 7.94 14.36 10.99

AFT Pharmaceuticals Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.30 18.85 4.02 16.04 2.04

Competitive Comparison of AFT Pharmaceuticals's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AFT Pharmaceuticals's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's Operating Margin % distribution charts can be found below:

* The bar in red indicates where AFT Pharmaceuticals's Operating Margin % falls into.



AFT Pharmaceuticals Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

AFT Pharmaceuticals's Operating Margin % for the fiscal year that ended in Mar. 2023 is calculated as

Operating Margin %=Operating Income (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=15.923 / 144.89
=10.99 %

AFT Pharmaceuticals's Operating Margin % for the quarter that ended in Sep. 2023 is calculated as

Operating Margin %=Operating Income (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=1.562 / 76.59
=2.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AFT Pharmaceuticals  (ASX:AFP) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


AFT Pharmaceuticals Operating Margin % Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


AFT Pharmaceuticals (ASX:AFP) Business Description

Traded in Other Exchanges
Address
129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

AFT Pharmaceuticals (ASX:AFP) Headlines

No Headlines